Bosh sahifa009420 ā¢ KRX
add
Hanall Biopharma Co Ltd
Yopilish kursi
49Ā 500,00Ā ā©
Kunlik diapazon
48Ā 350,00Ā ā© - 52Ā 000,00Ā ā©
Yillik diapazon
28Ā 500,00Ā ā© - 52Ā 000,00Ā ā©
Bozor kapitalizatsiyasi
2,62Ā trln KRW
OŹ»rtacha hajm
847,63Ā ming
Narx/foyda
-
Dividend daromadliligi
-
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 31,59Ā mlrd | -23,72% |
Joriy xarajat | 18,92Ā mlrd | -1,48% |
Sof foyda | -3,32Ā mlrd | -145,49% |
Sof foyda marjasi | -10,52 | -159,64% |
Har bir ulushga tushum | ā | ā |
EBITDA | -2,25Ā mlrd | -125,64% |
Amaldagi soliq stavkasi | -7,66% | ā |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 35,98Ā mlrd | -33,20% |
Jami aktivlari | 212,91Ā mlrd | -6,30% |
Jami passivlari | 42,61Ā mlrd | -14,65% |
Umumiy kapital | 170,30Ā mlrd | ā |
Tarqatilgan aksiyalar | 50,71Ā mln | ā |
Narxi/balansdagi bahosi | 14,74 | ā |
Aktivlardan daromad | -3,52% | ā |
Kapitaldan daromad | -4,35% | ā |
Pul aylanmasi
Naqd pulning sof oŹ»zgarishi
| (KRW) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -3,32Ā mlrd | -145,49% |
Operatsiyalardan naqd pul | -2,21Ā mlrd | 32,82% |
Sarmoyadan naqd pul | -10,12Ā mlrd | -315,68% |
Moliyadan naqd pul | -236,08Ā mln | -27,46% |
Naqd pulning sof oŹ»zgarishi | -12,56Ā mlrd | -114,38% |
BoŹ»sh pul | -8,51Ā mlrd | 6,63% |
Haqida
Tashkil etilgan
1973
Bosh ofis
Sayt
Xodimlar soni
306
